REPIDOSE READY PULSE
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
04-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXFENDAZOLE
Available from:
Intervet Ireland Limited
ATC code:
QP52AC02
INN (International Name):
OXFENDAZOLE
Dosage:
1250 Milligram
Pharmaceutical form:
Bolus
Prescription type:
LM-Licensed Merchant
Therapeutic group:
Bovine
Therapeutic area:
Oxfendazole
Therapeutic indications:
Endoparasiticide
Authorization status:
Authorised
Authorization date:
2013-05-24
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Repidose Ready Pulse
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Pulsatile release, intraruminal device.
Each tablet is a blue annular tablet with a slight bevel on the outside-edge.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle weighing between 100 kg and 400 kg.
Each tablet contains:
Active Substance
Oxfendazole
1250 mg
Excipients
Indigo Carmine (F.D. & C Blue No. 2) Aluminium Lake (E132)
20 mg
For a full list of excipients, see section 6.1
Bolus contains
7 tablets as above
1 PVC 7
th
tablet segment
6 PVC tablet segments
7 Silicone rubber sealing washers
1 Magnesium alloy core
1 Steel end-weight
1 PVC locking ring
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 17/07/2013_
_CRN 7015197_
_page number: 1_
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For administration to cattle weighing between 100 kg and 400 kg at the time the bolus is given.
In grazing cattle, the device will deliver seven doses of oxfendazole for the treatment of both adult and immature
gastro-intestinal roundworms and lungworms and tapeworms at regular intervals of approximately three weeks during a
period of about 18 weeks, the first dose being released within a few hours of administration. The device thus delivers a
programmed therapeutic anthelmintic dosing regime over a period of approximately 18 weeks from the time of dosing.
Oxfendazole is an established treatment for: Gastro-intestinal roundworms: _Ostertagia, Haemonchus,_
_Trichostrongylus, Nematodirus, Cooperia, Bunostomum, Capillaria, Oesophagostomum, Chabertia, Trichuris;_
Lungworms: _Dictyocaulus viviparus; _Tapeworms: _Moniezia_, heads and segments.
At the reco
Read the complete document
